A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 8, 2011, Pages 996-1004

  Lin, H H ^a,b,c   Langley, I ^d   Mwenda, R ^e   Doulla, B ^f   Egwaga, S ^f   Millington, K A ^d   Mann, G H ^d   Murray, M ^g   Squire, S B ^d   Cohen, Ted ^g,h  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c MENNONITE CHRISTIAN HOSPITAL   (Taiwan)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e MINISTRY OF HEALTH   (Malawi)

^f MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Modelling; Simulation; TB diagnostics; Transmission

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; CONCEPTUAL FRAMEWORK; DIAGNOSTIC PROCEDURE; HEALTH CARE PLANNING; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROCESS MODEL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; COMPUTER SIMULATION; DECISION SUPPORT TECHNIQUES; FEEDBACK; HEALTH CARE COSTS; HEALTH POLICY; HEALTH RESOURCES; HUMANS; POLICY MAKING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TUBERCULOSIS;

EID: 79955841901     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0062     Document Type: Article

References (40)

1. Marais B J, Brittle W, Painczyk K, et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis 2008; 47: 203-207. (Pubitemid 351920621)
2. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2005; 5: 62.
3. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
4. Ramsay A, Yassin M A, Cambanis A, et al. Front-loading sputum microscopy services: an opportunity to optimise smearbased case detection of tuberculosis in high prevalence countries. J Trop Med 2009; 2009: 398767.
5. Mase S R, Ramsay A, Ng V, et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007; 11: 485-495. (Pubitemid 46732633)
6. Angeby K A, Hoffner S E, Diwan V K. Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person analysis. Int J Tuberc Lung Dis 2004; 8: 806-815.
7. van Kampen S C, Ramsay A R, Anthony R M, Klatser P R. Retooling national TB control programmes (NTPs) with new diagnostics: the NTP perspective. PLoS One 2010; 5: e11649.
8. Wallis R S, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 1920-1937.
9. Pai M, Ramsay A, O'Brien R. Evidence-based tuberculosis diagnosis. PLoS Med 2008; 5: e156.
10. Mann G, Squire S B, Bissell K, et al. Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools. Int J Tuberc Lung Dis 2010; 14: 1518-1524.
11. Small P M, Pai M. Tuberculosis diagnosis - time for a game change. N Engl J Med 2010; 363: 1070-1071.
12. Small P M. Strengthening laboratory services for today and tomorrow. Int J Tuberc Lung Dis 2008; 12: 1105-1109.
13. Perkins M D, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 2007; 196 (Suppl 1): S15-S27. (Pubitemid 47206081)
14. Kemp J R, Mann G, Simwaka B N, Salaniponi F M, Squire S B. Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe. Bull World Health Organ 2007; 85: 580-585. (Pubitemid 47333815)
15. Squire S B, Belaye A K, Kashoti A, et al. 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 2005; 9: 25-31.
16. Creek T L, Lockman S, Kenyon T A, et al. Completeness and timeliness of treatment initiation after laboratory diagnosis of tuberculosis in Gaborone, Botswana. Int J Tuberc Lung Dis 2000; 4: 956-961.
17. Nyirenda T, Harries A D, Banerjee A, Salaniponi F M. Registration and treatment of patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1998; 2: 944-945. (Pubitemid 28539482)
18. Robinson S. Simulation: the practice of model development and use. Warwick, UK: Warwick Business School, University of Warwick: John Wiley & Sons, 2003.
19. Lanner. Case studies. Redditch, UK: Lanner, 2008-2011. http://www.lanner.com/en/case-studies.cfm?offset=6 Accessed May 2011.
20. SIMUL8 Corporation. Case studies. Boston, MA, USA: SIMUL8 Corporation, 2011. http://www.simul8.com/solutions/case-studies/ Accessed May 2011.
21. Günal M, Pidd M. Discrete event simulation for performance modelling in health care: a review of the literature. J Simulation 2010; 4: 42-51.
22. Brailsford S, Harper P, Patel B, Pitt M. An analysis of the academic literature on simulation and modelling in health care. J Simulation 2009; 3: 130-140.
23. Williams E J, VanBelle R. Exploring alternatives in an automotive industry job shop using simulation. Simulation 2005; 81: 637.
24. Mayer G, Spieckermann S. Life-cycle of simulation models: requirements and case studies in the automotive industry. J Simulation 2010; 4: 255-259.
25. Siebers P, Aickelin U, Celia H, Clegg C. Towards the development of a simulator for investigating the impact of people management practices on retail performance. J Simulation 2010; http://dx.doi.org/10.1057/jos.2010.20.
26. Katsaliaki K, Mustafee N. Applications of simulation research within the healthcare context. J Oper Research Society 2011; 62: 1431-1451.
27. Rauner M S, Brailsford S C, Flessa S. Use of discrete-event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries. J Oper Research Society 2005; 56: 222-233. (Pubitemid 40212818)
28. Anderson R M, May R M. Infectious diseases of humans: dynamics and control. Oxford, UK: Oxford University Press, 1991.
29. Murray C J, Salomon J A. Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 1998; 95: 13881-13886. (Pubitemid 28523067)
30. Baltussen R, Floyd K, Dye C. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 2005; 331: 1364.
31. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009.
32. Blower S M, McLean A R, Porco T C, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med 1995; 1: 815-821.
33. Abu-Raddad L J, Sabatelli L, Achterberg J T, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 2009; 106: 13980-13985.
34. Dowdy D W, Chaisson R E, Maartens G, Corbett E L, Dorman S E. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci USA 2008; 105: 11293-11298.
35. Stop TB Partnership's New Diagnostics Working Group WHO. Pathways to better diagnostics for tuberculosis: a blueprint for the development of TB diagnostics. Geneva, Switzerland: WHO, 2009.
36. Steingart K R, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 570-581. (Pubitemid 44262344)
37. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792. (Pubitemid 351490566)
38. Soares-Weiser K, Bravo Vergel Y, Beynon S, et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol Assess 2007; 11: iii-iv, ix-206.
39. World Health Organization. WHO endorses new rapid tuberculosis test. Geneva, Switzerland: WHO, 2011. http://www.who.int/tb/laboratory/new-rapid-test/ en/index.html Accessed May 2011.
40. World Health Organization. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/laboratory/roadmap-xpert-mtb-rif-rev23dec2010.pdf Accessed May 2011.